Eiger BioPharmaceuticals Inc (EIGRQ)
2.30
+0.15
(+6.98%)
USD |
OTCM |
May 31, 16:00
Eiger BioPharmaceuticals Total Assets (Quarterly): 38.83M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 38.83M |
| September 30, 2023 | 55.65M |
| June 30, 2023 | 72.36M |
| March 31, 2023 | 99.23M |
| December 31, 2022 | 120.14M |
| September 30, 2022 | 143.74M |
| June 30, 2022 | 163.69M |
| March 31, 2022 | 153.33M |
| December 31, 2021 | 126.40M |
| September 30, 2021 | 140.28M |
| June 30, 2021 | 156.84M |
| March 31, 2021 | 175.52M |
| December 31, 2020 | 143.59M |
| September 30, 2020 | 140.69M |
| June 30, 2020 | 103.16M |
| March 31, 2020 | 88.42M |
| December 31, 2019 | 105.14M |
| September 30, 2019 | 120.00M |
| June 30, 2019 | 132.93M |
| March 31, 2019 | 93.11M |
| December 31, 2018 | 102.45M |
| September 30, 2018 | 67.38M |
| Date | Value |
|---|---|
| June 30, 2018 | 75.34M |
| March 31, 2018 | 34.22M |
| December 31, 2017 | 42.88M |
| September 30, 2017 | 33.28M |
| June 30, 2017 | 41.46M |
| March 31, 2017 | 49.77M |
| December 31, 2016 | 60.74M |
| September 30, 2016 | 57.43M |
| June 30, 2016 | 46.77M |
| March 31, 2016 | 61.87M |
| December 31, 2015 | 33.89M |
| September 30, 2015 | 38.24M |
| June 30, 2015 | 59.95M |
| March 31, 2015 | 73.24M |
| December 31, 2014 | 89.11M |
| September 30, 2014 | 96.91M |
| June 30, 2014 | 52.28M |
| March 31, 2014 | 58.58M |
| December 31, 2013 | 21.15M |
| September 30, 2013 | 24.59M |
| June 30, 2013 | 28.39M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
38.83M
Minimum
Dec 2023
175.52M
Maximum
Mar 2021
120.00M
Average
126.40M
Median
Dec 2021
Total Assets (Quarterly) Benchmarks
| AngioDynamics Inc | 324.84M |
| Pulse Biosciences Inc | 49.16M |
| Outset Medical Inc | 346.24M |
| Allurion Technologies Inc | 59.99M |
| Candel Therapeutics Inc | 31.22M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 53.28M |
| Shareholders Equity (Quarterly) | -14.46M |
| Debt to Equity Ratio | -2.844 |
| Current Ratio | 0.7101 |
| Net Debt Paydown Yield | -3.62% |